SARS-CoV-2 structural features may explain limited neutralizing-antibody responses

被引:44
作者
Bachmann, Martin F. [1 ,2 ,3 ]
Mohsen, Mona O. [2 ,3 ]
Zha, Lisha [1 ]
Vogel, Monique [1 ]
Speiser, Daniel E. [4 ,5 ]
机构
[1] Anhui Agr Univ, Int Immunol Ctr, Hefei, Peoples R China
[2] Univ Hosp Bern, Dept Rheumatol Immunol & Allergol, Bern, Switzerland
[3] Univ Bern, Dept BioMed Res, Bern, Switzerland
[4] Univ Hosp, Lausanne, Switzerland
[5] Univ Lausanne, Lausanne, Switzerland
基金
瑞士国家科学基金会;
关键词
CORONAVIRUS; IMMUNITY; CELL; ANTIGEN; IMMUNOGENICITY; INFECTION;
D O I
10.1038/s41541-020-00264-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Neutralizing antibody responses of SARS-CoV-2-infected patients may be low and of short duration. We propose here that coronaviruses employ a structural strategy to avoid strong and enduring antibody responses. Other viruses induce optimal and long-lived neutralizing antibody responses, thanks to 20 or more repetitive, rigid antigenic epitopes, spaced by 5-10nm, present on the viral surface. Such arrays of repetitive and highly organized structures are recognized by the immune system as pathogen-associated structural patterns (PASPs), which are characteristic for pathogen surfaces. In contrast, coronaviruses are large particles with long spikes (S protein) embedded in a fluid membrane. Therefore, the neutralizing epitopes (which are on the S protein) are loosely "floating" and widely spaced by an average of about 25nm. Consequently, recruitment of complement is poor and stimulation of B cells remains suboptimal, offering an explanation for the inefficient and short-lived neutralizing antibody responses.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2
    Shi, Rui
    Shan, Chao
    Duan, Xiaomin
    Chen, Zhihai
    Liu, Peipei
    Song, Jinwen
    Song, Tao
    Bi, Xiaoshan
    Han, Chao
    Wu, Lianao
    Gao, Ge
    Hu, Xue
    Zhang, Yanan
    Tong, Zhou
    Huang, Weijin
    Liu, William Jun
    Wu, Guizhen
    Zhang, Bo
    Wang, Lan
    Qi, Jianxun
    Feng, Hui
    Wang, Fu-Sheng
    Wang, Qihui
    Gao, George Fu
    Yuan, Zhiming
    Yan, Jinghua
    NATURE, 2020, 584 (7819) : 120 - +
  • [32] Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses
    Schmidt, Fabian
    Weisblum, Yiska
    Muecksch, Frauke
    Hoffmann, Hans-Heinrich
    Michailidis, Eleftherios
    Lorenzi, Julio C. C.
    Mendoza, Pilar
    Rutkowska, Magdalena
    Bednarski, Eva
    Gaebler, Christian
    Agudelo, Marianna
    Cho, Alice
    Wang, Zijun
    Gazumyan, Anna
    Cipolla, Melissa
    Caskey, Marina
    Robbiani, Davide F.
    Nussenzweig, Michel C.
    Rice, Charles M.
    Hatziioannou, Theodora
    Bieniasz, Paul D.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2020, 217 (11)
  • [33] Immunological imprinting shapes the specificity of human antibody responses SARS-CoV-2 variants
    Johnston, Timothy S.
    Li, Shuk Hang
    Painter, Mark M.
    Atkinson, Reilly K.
    Douek, Naomi R.
    Reeg, David B.
    Douek, Daniel C.
    Wherry, E. John
    Hensley, Scott E.
    IMMUNITY, 2024, 57 (04) : 912 - 925.e4
  • [34] Imprinted antibody responses against SARS-CoV-2 Omicron sublineages
    Park, Young-Jun
    Pinto, Dora
    Walls, Alexandra C.
    Liu, Zhuoming
    De Marco, Anna
    Benigni, Fabio
    Zatta, Fabrizia
    Silacci-Fregni, Chiara
    Bassi, Jessica
    Sprouse, Kaitlin R.
    Addetia, Amin
    Bowen, John E.
    Stewart, Cameron
    Giurdanella, Martina
    Saliba, Christian
    Guarino, Barbara
    Schmid, Michael A.
    Franko, Nicholas M.
    Logue, Jennifer K.
    Dang, Ha V.
    Hauser, Kevin
    di Iulio, Julia
    Rivera, William
    Schnell, Gretja
    Rajesh, Anushka
    Zhou, Jiayi
    Farhat, Nisar
    Kaiser, Hannah
    Montiel-Ruiz, Martin
    Noack, Julia
    Lempp, Florian A.
    Janer, Javier
    Abdelnabi, Rana
    Maes, Piet
    Ferrari, Paolo
    Ceschi, Alessandro
    Giannini, Olivier
    De Melo, Guilherme Dias
    Kergoat, Lauriane
    Bourhy, Herve
    Neyts, Johan
    Soriaga, Leah
    Purcell, Lisa A.
    Snell, Gyorgy
    Whelan, Sean P. J.
    Lanzavecchia, Antonio
    Virgin, Herbert W.
    Piccoli, Luca
    Chu, Helen Y.
    Pizzuto, Matteo Samuele
    SCIENCE, 2022, 378 (6620) : 619 - +
  • [35] Antibody responses to SARS-CoV-2 in patients with COVID-19
    Long, Quan-Xin
    Liu, Bai-Zhong
    Deng, Hai-Jun
    Wu, Gui-Cheng
    Deng, Kun
    Chen, Yao-Kai
    Liao, Pu
    Qiu, Jing-Fu
    Lin, Yong
    Cai, Xue-Fei
    Wang, De-Qiang
    Hu, Yuan
    Ren, Ji-Hua
    Tang, Ni
    Xu, Yin-Yin
    Yu, Li-Hua
    Mo, Zhan
    Gong, Fang
    Zhang, Xiao-Li
    Tian, Wen-Guang
    Hu, Li
    Zhang, Xian-Xiang
    Xiang, Jiang-Lin
    Du, Hong-Xin
    Liu, Hua-Wen
    Lang, Chun-Hui
    Luo, Xiao-He
    Wu, Shao-Bo
    Cui, Xiao-Ping
    Zhou, Zheng
    Zhu, Man-Man
    Wang, Jing
    Xue, Cheng-Jun
    Li, Xiao-Feng
    Wang, Li
    Li, Zhi-Jie
    Wang, Kun
    Niu, Chang-Chun
    Yang, Qing-Jun
    Tang, Xiao-Jun
    Zhang, Yong
    Liu, Xia-Mao
    Li, Jin-Jing
    Zhang, De-Chun
    Zhang, Fan
    Liu, Ping
    Yuan, Jun
    Li, Qin
    Hu, Jie-Li
    Chen, Juan
    NATURE MEDICINE, 2020, 26 (06) : 845 - +
  • [36] Antibody and B cell responses to SARS-CoV-2 infection and vaccination
    Roltgen, Katharina
    Boyd, Scott D.
    CELL HOST & MICROBE, 2021, 29 (07) : 1063 - 1075
  • [37] Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain
    Yang, Mei
    Li, Jiaqi
    Huang, Zhaoxia
    Li, Heng
    Wang, Yueming
    Wang, Xiaoli
    Kang, Sisi
    Huang, Xing
    Wu, Changwen
    Liu, Tong
    Jia, Zhenxing
    Liang, Junlang
    Yuan, Xiaohui
    He, Suhua
    Chen, Xiaoxue
    Zhou, Zhechong
    Chen, Qiuyue
    Liu, Siqi
    Li, Jing
    Zheng, Huiwen
    Liu, Xi
    Li, Kenan
    Yao, Xiaojun
    Lang, Bin
    Liu, Longding
    Liao, Hua-Xin
    Chen, Shoudeng
    MICROBIOLOGY SPECTRUM, 2021, 9 (02):
  • [38] Neutralizing and enhancing antibodies against SARS-CoV-2
    Liu, Yafei
    Arase, Hisashi
    INFLAMMATION AND REGENERATION, 2022, 42 (01)
  • [39] A community study of neutralizing antibodies against SARS-CoV-2 in China
    Lv, Yitong
    Huang, Lei
    Wang, Junhu
    He, Hui
    Song, Libo
    He, Jia
    Xu, Lida
    Yu, Changyuan
    Mei, Ying
    Gao, Qi
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [40] Duration of SARS-CoV-2 Serum-Neutralizing Antibodies Against SARS-CoV-2 Dependent on the Individual
    Li, Jin
    Zou, Li
    Li, Shaojie
    Zou, Ruogu
    Fang, Zhixiong
    Zhang, Pingan
    Li, Huijun
    Wang, Shanshan
    Ke, Dong
    Gao, Peng
    Jin, Cuicui
    Fang, Cong
    Zhou, Ji
    He, Ellen
    Skog, Sven
    VIRAL IMMUNOLOGY, 2023, 36 (03) : 153 - 162